Le Lézard
Classified in: Science and technology
Subject: Personnel

Michael Egan Appointed to AtScale's Board of Directors


AtScale, the leading provider of semantic layer solutions for analytics and Generative AI, is proud to announce the appointment of Michael Egan to its esteemed Board of Directors, effective immediately. Mr. Egan brings a wealth of experience from the technology and venture capital sectors, enhancing AtScale's already dynamic leadership team.

With a career spanning over three decades, Michael Egan has been the Managing Member of venture capital firm Carruth Management LLC since 1991. In addition to his role at Carruth Management, Mr. Egan serves as the President of Three Bays Preservation Inc., is a Partner of the Fenway Sports Group (Boston Red Sox) and is the Director of the Liverpool Football Club.

Mr. Egan's career journey commenced at EMC, where he served as the Vice President of Products. This early experience provided the foundation for his illustrious career, characterized by innovation, leadership, and a profound understanding of the technology landscape.

Chris Lynch, CEO of AtScale, expressed his enthusiasm about the latest addition to the Board, stating, "We are thrilled to welcome Mike Egan to AtScale's Board of Directors. His profound knowledge of the technology landscape and his successful track record in venture capital make him a valuable addition to our team." Further, "Mr. Egan's impact on entrepreneurship in Boston, the technology industry, and the globe in general is well documented. We at AtScale are excited to aspire to the bar set by them."

In his reflections on this new role, Mr. Egan shared, "I've closely observed AtScale's growth and success with great interest and am honored to join the organization. I eagerly anticipate contributing to AtScale's mission of empowering enterprises to harness the transformative potential of data and analytics."

The entire AtScale Board of Directors is enthusiastic about the addition of Mr. Egan, and they look forward to the valuable insights and leadership he will bring to the team.

About AtScale 
AtScale enables smarter decision-making by accelerating the flow of data-driven insights. The company's semantic layer platform simplifies, accelerates, and extends business intelligence and data science capabilities for enterprise customers across all industries. With AtScale, customers are empowered to democratize data, implement self-service BI, and build a more agile analytics infrastructure for better, more impactful decision making. For more information, please visit www.atscale.com and follow us on LinkedIn, Twitter, or Facebook.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: